Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients
Keywords: ناتالیزوماب; Multiple sclerosis; Natalizumab; sL-selectin; Anti-JCV antibody index; Progressive multifocal leukoencephalopathy; Biomarkers;